Long-Term Follow-Up Highlights Sustained Efficacy, Immunogenicity, and Safety for GlaxoSmithKline's HPV Vaccine

The sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix has been highlighted in a long-term follow-up study. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than nine years, and vaccine efficacy (VE) against incident infection was 100%. This is the longest follow-up report for a licensed HPV vaccine. Visit http://ift.tt/1rYeSyT for ...

via Medindia Health News More READ

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1ks241r